🇺🇸 Control 1 in United States

13 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Pyrexia — 2 reports (15.38%)
  2. Respiratory Depression — 2 reports (15.38%)
  3. Weight Decreased — 2 reports (15.38%)
  4. Abnormal Dreams — 1 report (7.69%)
  5. Application Site Pain — 1 report (7.69%)
  6. Application Site Pruritus — 1 report (7.69%)
  7. Delirium — 1 report (7.69%)
  8. Drug Interaction — 1 report (7.69%)
  9. Headache — 1 report (7.69%)
  10. Hepatic Encephalopathy — 1 report (7.69%)

Source database →

Control 1 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Control 1 approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Control 1 in United States?

Aydin Adnan Menderes University is the originator. The local marketing authorisation holder may differ — check the official source linked above.